Navigation Links
PointCross Life Sciences' SENDBox and SEND-as-a-Service Prepare Pharma Companies to Comply with the FDA's Upcoming e-Data Submission Mandate

FOSTER CITY, Calif., March 11, 2013 /PRNewswire/ -- As a result of PDUFA V, the FDA will soon require Biopharma companies to submit their nonclinical study data in standardized electronic formats such as CDISC SEND, the Standard for the Exchange of Nonclinical Data.  This will enable reviewers to analyze all the studies across species in a submission, and to detect weak or important toxicity signals in the data. To help Biopharma companies and their CROs prepare for such regulatory analytics, PointCross Life Sciences announces the immediate availability of its SENDBox™ and SEND-as-a-Service™ offerings.

Biopharma companies and CROs can use the SENDBox™ to assemble data from GLP validated data collection systems, transform them into SEND, and view them before submission.  SENDBox is offered with tools to meet Computer Systems Validation requirements.  It is available as an Enterprise solution behind company firewalls or as a Cloud-hosted service.  SENDBox is based on and compatible with DSIMS®, the engine behind the FDA's SEND-compliant Nonclinical Information Management System (NIMS).  NIMS helps the Agency to better evaluate the safety impact of drugs and improve reviewer efficiency.

SEND-as-a-Service is a Cloud-hosted offering intended for sponsors and CROs who simply wish to outsource the packaging of their disparate datasets, current or past, into SEND.  This service converts their data into SEND ready packages for submission or for analyzing their data in the same way as reviewers.

According to Dr. Shree Nath , VP of PointCross Life Sciences, "The Biopharma industry is moving quickly to become ready for the FDA's upcoming e-data submission directive.  Three top Sponsor companies have selected PointCross to deliver their SEND implementations after a careful evaluation of other providers.  Clients now have the flexibility of deploying the SENDBox solution and assembling SEND datasets themselves, or have our experts do it for them through SEND-as-a-Service.  These new offerings complement our proven DSIMS solution and provide large, mid-size and small Biopharma companies with options that best fit with their business needs."

About PointCross Life Sciences, Inc.

PointCross Life Sciences, Inc. is a global provider of Big Data analytics, data store and translational informatics solutions and services for safety detection across large, disparate, and weakly structured datasets.  Our offerings are used by researchers and reviewers involved with drug development, and are available behind the Enterprise firewall or on the Cloud.  Our clients include several global Biopharma companies as well as the FDA. PointCross Life Sciences is a wholly owned subsidiary of PointCross, Inc.

Dr. Shree Nath , VP, 
PointCross Life Sciences, Inc. 
1291 E. Hillsdale Blvd., Suite 304
Foster City, CA 94404 
1-866-468-1900 or

SOURCE PointCross Life Sciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. For International Life Sciences, Biotech and Pharmaceutical Events, Top Executives Turn to Global Information
2. Sangamo BioSciences Announces Presentation At The Barclays Global Healthcare Conference
3. Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
4. Dr. Joachim Schorr (PhD) zum Chief Scientific Officer von Caris Life Sciences bestellt
5. Joachim Schorr, PhD, Named Chief Scientific Officer at Caris Life Sciences
6. Presage Biosciences Announces Strategic Research Alliance with Celgene Corporation
7. Heptares to Present at the 6th Annual European Life Sciences CEO Forum (5-6 March)
8. Sangamo BioSciences Announces Presentation At 33rd Annual Cowen And Company Health Care Conference
9. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
10. BioDelivery Sciences to Host Buprenorphine Investor and Analyst Event
11. London Health Sciences Centre Announces Firsts in Treatment Option for Blood Circulation
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Research and ... News Issue 52" report to their offering. ... influenza treatment creates a favourable commercial environment for MedImmune to ... patient base that will serve to drive considerable growth for ... would serve to cap sales considerably, but development is still ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Surgical Procedure Volumes: Global Analysis (United States, ... Australia, Canada)" report to their offering. ... an essential tool for healthcare business planners, provides surgical ... looks at surgery trends with an in-depth analysis of ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):